These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 23933078)
41. Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity. Vogels R; Zuijdgeest D; van Rijnsoever R; Hartkoorn E; Damen I; de Béthune MP; Kostense S; Penders G; Helmus N; Koudstaal W; Cecchini M; Wetterwald A; Sprangers M; Lemckert A; Ophorst O; Koel B; van Meerendonk M; Quax P; Panitti L; Grimbergen J; Bout A; Goudsmit J; Havenga M J Virol; 2003 Aug; 77(15):8263-71. PubMed ID: 12857895 [TBL] [Abstract][Full Text] [Related]
42. Efficient clinical scale gene modification via zinc finger nuclease-targeted disruption of the HIV co-receptor CCR5. Maier DA; Brennan AL; Jiang S; Binder-Scholl GK; Lee G; Plesa G; Zheng Z; Cotte J; Carpenito C; Wood T; Spratt SK; Ando D; Gregory P; Holmes MC; Perez EE; Riley JL; Carroll RG; June CH; Levine BL Hum Gene Ther; 2013 Mar; 24(3):245-58. PubMed ID: 23360514 [TBL] [Abstract][Full Text] [Related]
43. [Characterization of adenovirus serotype 35 vectors using genetically modified animals and non-human primates]. Sakurai F; Kawabata K; Mizuguchi H Yakugaku Zasshi; 2006 Nov; 126(11):1013-9. PubMed ID: 17077607 [TBL] [Abstract][Full Text] [Related]
44. [Development of a replication-incompetent adenovirus vector derived from subgroup B adenovirus serotype 35]. Sakurai F Yakugaku Zasshi; 2008 Dec; 128(12):1751-61. PubMed ID: 19043294 [TBL] [Abstract][Full Text] [Related]
45. Efficient adenovirus-mediated gene transfer into primary T cells and thymocytes in a new coxsackie/adenovirus receptor transgenic model. Hurez V; Dzialo-Hatton R; Oliver J; Matthews RJ; Weaver CT BMC Immunol; 2002 May; 3():4. PubMed ID: 12019030 [TBL] [Abstract][Full Text] [Related]
46. Intradermal delivery of adenoviral type-35 vectors leads to high efficiency transduction of mature, CD8+ T cell-stimulating skin-emigrated dendritic cells. de Gruijl TD; Ophorst OJ; Goudsmit J; Verhaagh S; Lougheed SM; Radosevic K; Havenga MJ; Scheper RJ J Immunol; 2006 Aug; 177(4):2208-15. PubMed ID: 16887980 [TBL] [Abstract][Full Text] [Related]
47. Chimeric Ad5 vectors expressing the short fiber of Ad41 show reduced affinity for human intestinal epithelium. Kesisoglou F; Chamberlain JR; Schmiedlin-Ren P; Kaz A; Fleisher D; Roessler B; Zimmermann EM Mol Pharm; 2005; 2(6):500-8. PubMed ID: 16323957 [TBL] [Abstract][Full Text] [Related]
48. Highly efficient gene transfer using a retroviral vector into murine T cells for preclinical chimeric antigen receptor-expressing T cell therapy. Kusabuka H; Fujiwara K; Tokunaga Y; Hirobe S; Nakagawa S; Okada N Biochem Biophys Res Commun; 2016 Apr; 473(1):73-79. PubMed ID: 26993168 [TBL] [Abstract][Full Text] [Related]
49. High-efficiency transduction of freshly isolated human tumor cells using adenoviral interleukin-2 vectors. Leimig T; Brenner M; Ramsey J; Vanin E; Blaese M; Dilloo D Hum Gene Ther; 1996 Jun; 7(10):1233-9. PubMed ID: 8793547 [TBL] [Abstract][Full Text] [Related]
50. Transient Chimeric Ad5/37 Fiber Enhances NK-92 Carrier Cell-Mediated Delivery of Oncolytic Adenovirus Type 5 to Tumor Cells. Gao J; Zhang W; Mese K; Bunz O; Lu F; Ehrhardt A Mol Ther Methods Clin Dev; 2020 Sep; 18():376-389. PubMed ID: 32695840 [TBL] [Abstract][Full Text] [Related]
51. Genetically modified adenoviral vector with the protein transduction domain of Tat improves gene transfer to CAR-deficient cells. Liu S; Mao Q; Zhang W; Zheng X; Bian Y; Wang D; Li H; Chai L; Zhao J; Xia H Biosci Rep; 2009 Apr; 29(2):103-9. PubMed ID: 18721127 [TBL] [Abstract][Full Text] [Related]
52. Chimeric adenoviral vectors incorporating a fiber of human adenovirus 3 efficiently mediate gene transfer into prostate cancer cells. Murakami M; Ugai H; Belousova N; Pereboev A; Dent P; Fisher PB; Everts M; Curiel DT Prostate; 2010 Mar; 70(4):362-76. PubMed ID: 19902467 [TBL] [Abstract][Full Text] [Related]
53. Transduction of human bone marrow by adenoviral vector. Mitani K; Graham FL; Caskey CT Hum Gene Ther; 1994 Aug; 5(8):941-8. PubMed ID: 7948143 [TBL] [Abstract][Full Text] [Related]
54. Strategies to accomplish targeted gene delivery to muscle cells employing tropism-modified adenoviral vectors. Douglas JT; Curiel DT Neuromuscul Disord; 1997 Jul; 7(5):284-98. PubMed ID: 9267842 [TBL] [Abstract][Full Text] [Related]
55. Adenoviral/retroviral vector chimeras: a novel strategy to achieve high-efficiency stable transduction in vivo. Bilbao G; Feng M; Rancourt C; Jackson WH; Curiel DT FASEB J; 1997 Jul; 11(8):624-34. PubMed ID: 9240964 [TBL] [Abstract][Full Text] [Related]
56. Vaccination inhibits the human adenoviral transduction in a mouse keratoconjunctivitis model. Fukuda M; Nakamura J; Ito S; Kawazoe K; Miyanaga Y; Teshigawara T; Okuda K; Mizuki N; Shimada M Vaccine; 2021 Jun; 39(26):3498-3508. PubMed ID: 34016474 [TBL] [Abstract][Full Text] [Related]
57. Effect of adenoviral vector infection on cell proliferation in cultured primary human airway epithelial cells. Teramoto S; Johnson LG; Huang W; Leigh MW; Boucher RC Hum Gene Ther; 1995 Aug; 6(8):1045-53. PubMed ID: 7578417 [TBL] [Abstract][Full Text] [Related]
58. Improvement of adenoviral vector-mediated gene transfer to airway epithelia by folate-modified anionic liposomes. Zhong Z; Wan Y; Han J; Shi S; Zhang Z; Sun X Int J Nanomedicine; 2011; 6():1083-93. PubMed ID: 21698075 [TBL] [Abstract][Full Text] [Related]